We are live on
!
Find out more
B
Bailard Portfolio holdings
AUM
$4.35B
1-Year Est. Return
23.57%
This Fund
S&P 500
This Quarter
Est. Return
+8.43%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$2.79B
AUM Growth
+$166M
(+6.3%)
Cap. Flow
-$5.09M
Cap. Flow
% of AUM
-0.18%
Top 10 Holdings %
Top 10 Hldgs %
29.11%
Holding
816
New
115
Increased
259
Reduced
230
Closed
106
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$64M |
| 2 |
IBTE
iShares iBonds Dec 2024 Term Treasury ETF
IBTE
|
+$16.4M |
| 3 |
iShares National Muni Bond ETF
MUB
|
+$14M |
| 4 |
iShares California Muni Bond ETF
CMF
|
+$7.81M |
| 5 |
Advanced Micro Devices
AMD
|
+$7.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 Value ETF
IWN
|
+$54.9M |
| 2 |
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
|
+$39.6M |
| 3 |
Vanguard Small-Cap Value ETF
VBR
|
+$10.5M |
| 4 |
iShares Short-Term National Muni Bond ETF
SUB
|
+$9.32M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$6.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.23% |
| 2 | Healthcare | 8.44% |
| 3 | Financials | 6.47% |
| 4 | Industrials | 4.52% |
| 5 | Consumer Discretionary | 4.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMRX
701
DELISTED
Chimerix, Inc.
CMRX
| $42.3K | ﹤0.01% |
+33,600
| New | +$54.8K |
|
702
Paysign
PAYS
$486M
| $41.4K | ﹤0.01% |
+11,400
| New | +$38.9K |
|
|
AGIL
703
DELISTED
AgileThought Inc
AGIL
| $41K | ﹤0.01% |
+13,000
| New | +$53.1K |
|
704
Gevo
GEVO
$397M
| $40.5K | ﹤0.01% |
26,300
| – | – |
|
|
KRON
705
DELISTED
Kronos Bio
KRON
| $40.4K | ﹤0.01% |
+27,700
| New | +$53.1K |
|
706
Bolt Biotherapeutics
BOLT
$7.36M
| $39.6K | ﹤0.01% |
+1,425
| New | +$41.7K |
|
707
Trevi Therapeutics
TRVI
$2.49B
| $39.2K | ﹤0.01% |
21,200
| – | – |
|
708
Ovid Therapeutics
OVID
$435M
| $32.5K | ﹤0.01% |
12,600
| – | – |
|
|
VIRX
709
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $31.6K | ﹤0.01% |
+19,900
| New | +$36.2K |
|
|
TRML
710
DELISTED
Tourmaline Bio
TRML
| $27.8K | ﹤0.01% |
+1,477
| New | +$24.4K |
|
711
Ameris Bancorp
ABCB
$5.9B
| – | – |
-5,258
| Closed | -$248K |
|
|
AIV
712
Aimco
AIV
$380M
| – | – |
-54,695
| Closed | -$389K |
|
713
Alkermes
ALKS
$8.82B
| – | – |
-8,087
| Closed | -$211K |
|
714
Ametek
AME
$55.5B
| – | – |
-1,497
| Closed | -$209K |
|
715
AMN Healthcare
AMN
$1.28B
| – | – |
-2,000
| Closed | -$206K |
|
|
GOLD
716
Gold.com Inc
GOLD
$1.14B
| – | – |
-7,994
| Closed | -$278K |
|
717
American Public Education
APEI
$875M
| – | – |
-20,232
| Closed | -$249K |
|
718
Apogee Enterprises
APOG
$850M
| – | – |
-10,764
| Closed | -$479K |
|
|
ARI
719
Apollo Commercial Real Estate
ARI
$887M
| – | – |
-22,640
| Closed | -$244K |
|
720
A10 Networks
ATEN
$2.47B
| – | – |
-17,613
| Closed | -$293K |
|
|
DCH
721
Dauch Corp
DCH
$1.3B
| – | – |
-35,500
| Closed | -$278K |
|
722
Boise Cascade
BCC
$2.74B
| – | – |
-4,175
| Closed | -$287K |
|
723
BGSF Inc
BGSF
$59.1M
| – | – |
-13,421
| Closed | -$206K |
|
724
Benchmark Electronics
BHE
$2.91B
| – | – |
-21,800
| Closed | -$582K |
|
725
Brady Corp
BRC
$4.45B
| – | – |
-5,928
| Closed | -$279K |
|
Similar funds
EC
SFM
NHC
EQF
NEI
MYIA
Bailard's Q1 2023 Portfolio in Review
As of Q1 2023, Bailard held 816 positions worth $2.79B, up 6.3% from $2.63B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Bailard's Q1 2023 filing shows 115 new, 259 increased, 230 reduced and 106 closed positions. Its largest new stake was iShares iBonds Dec 2024 Term Treasury ETF: 688,090 shares worth $16.5M. The largest sale was iShares Russell 2000 Value ETF, an estimated $54.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Bailard's largest Q1 2023 buy was iShares iBonds Dec 2024 Term Treasury ETF: 688,090 shares worth $16.5M.
- Bailard added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $64M increase.
- Bailard's biggest Q1 2023 reduction was iShares Russell 2000 Value ETF, cutting an estimated $54.9M.
- Bailard fully exited Check Point Software Technologies in Q1 2023, selling an estimated $4.55M.
- Bailard's ten largest holdings make up 29% of its $2.79B portfolio in Q1 2023.
- Bailard opened 115 new positions and closed 106 in Q1 2023.
- Bailard's portfolio value rose 6.3% quarter-over-quarter to $2.79B.
Based on Bailard's 13F filing for Q1 2023, filed 8 May 2023.